Review: taking Lisinopril and Doxazosin mesylate together


Summary

Drug interactions are reported among people who take Lisinopril and Doxazosin mesylate together. This review analyzes the effectiveness and drug interactions between Lisinopril and Doxazosin mesylate. It is created by eHealthMe based on reports of 1,899 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Lisinopril and Doxazosin mesylate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lisinopril

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. (latest outcomes from Lisinopril 102,207 users)

Doxazosin Mesylate

Doxazosin mesylate has active ingredients of doxazosin mesylate. It is often used in high blood pressure. (latest outcomes from Doxazosin mesylate 7,794 users)

On Jul, 20, 2016

1,899 people who take Lisinopril, Doxazosin Mesylate are studied.


Number of reports submitted per year:

Lisinopril and Doxazosin mesylate drug interactions.

Drug effectiveness over time:

Lisinopril:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 66.0% - (4 of 6 people)
  • 1 - 2 years: 36.0% - (4 of 11 people)
  • 2 - 5 years: 45.0% - (9 of 20 people)
  • 5 - 10 years: 31.0% - (6 of 19 people)
  • 10+ years: 33.0% - (2 of 6 people)
  • not specified: 100.0% - (1 of 1 people)
Doxazosin Mesylate:
  • < 1 month: 14.0% - (1 of 7 people)
  • 1 - 6 months: 12.0% - (1 of 8 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 27.0% - (3 of 11 people)
  • 2 - 5 years: 41.0% - (5 of 12 people)
  • 5 - 10 years: 61.0% - (8 of 13 people)
  • 10+ years: 60.0% - (3 of 5 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lisinopril:
  • female: 18.0% - (2 of 11 people)
  • male: 43.0% - (25 of 57 people)
Doxazosin Mesylate:
  • female: 50.0% - (3 of 6 people)
  • male: 35.0% - (19 of 53 people)

Drug effectiveness by age:

Lisinopril:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 26.0% - (6 of 23 people)
  • 60+: 50.0% - (20 of 40 people)
Doxazosin Mesylate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 20.0% - (1 of 5 people)
  • 50-59: 31.0% - (5 of 16 people)
  • 60+: 42.0% - (16 of 38 people)

Most common drug interactions over time *:

< 1 month:
  • hypertension
  • asthenia
  • disturbance in attention
  • drug ineffective
  • eyelid oedema
  • hypotension
  • laceration
  • lightheadedness
  • somnolence
  • sweating increased
1 - 6 months:
  • asthenia
  • international normalised ratio increased
  • rectal haemorrhage
  • dizziness
  • hepatic failure
  • urinary tract infection
  • atrial fibrillation
  • clostridium difficile colitis
  • escherichia infection
  • liver disorder
6 - 12 months:
  • clavicle fracture
  • dizziness
  • tumour lysis syndrome
  • arrhythmia
  • gastrointestinal haemorrhage
  • low blood pressure
  • parkinson's disease
  • sleepiness - during the day
  • weakness
  • achilles tendonitis
1 - 2 years:
  • tubulointerstitial nephritis
  • glomerular filtration rate abnormal
  • dizziness
  • erectile dysfunction
  • low blood pressure
  • priapism
  • tiredness
  • aches and pains in bones
  • achilles tendonitis
  • asthenia
2 - 5 years:
  • bladder stones
  • cancer
  • dizziness
  • dyspepsia
  • erectile dysfunction
  • hypotension
  • muscle fatigue
  • palpitations
  • sleepiness - during the day
  • aches and pains in bones
5 - 10 years:
  • cough
  • dizziness
  • double vision
  • elevated potassium
  • laceration
  • lightheadedness
  • sweating increased
  • dyspepsia
  • arrhythmia
  • bladder infection
10+ years:
  • edema - peripheral, peripheral edema
  • high blood sugar
  • insomnia
  • tinnitus
not specified:
  • drug ineffective
  • pain
  • nausea
  • dyspnoea
  • dizziness
  • hypotension
  • fatigue
  • anxiety
  • cardiac failure congestive
  • asthenia

Most common drug interactions by gender *:

female:
  • drug ineffective
  • dizziness
  • hypotension
  • nausea
  • fatigue
  • atrial fibrillation
  • dyspnoea
  • hyperkalaemia
  • hypertension
  • headache
male:
  • pain
  • drug ineffective
  • anxiety
  • dyspnoea
  • nausea
  • asthenia
  • diarrhoea
  • injury
  • dizziness
  • hypotension

Most common drug interactions by age *:

0-1:
  • hydronephrosis
  • ureteric cancer
2-9:
  • anorexia
  • diarrhoea
  • loss of consciousness
  • nausea
  • paraesthesia
  • syncope
10-19:
  • cardiac arrest
  • coronary artery atherosclerosis
  • haemosiderosis
  • hyperparathyroidism secondary
  • renal osteodystrophy
  • sudden death unexplained
  • testicular torsion
20-29:
  • cardio-respiratory arrest
  • pneumocystis carinii pneumonia
  • pulmonary haemorrhage
  • brain oedema
  • infectious mononucleosis
  • lymphoproliferative disorder
  • cytomegalovirus infection
  • epstein-barr virus infection
  • renal atrophy
  • acidosis
30-39:
  • blood pressure decreased
  • cardio-respiratory arrest
  • catheter site infection
  • diabetes mellitus
  • hypertension
  • malaise
  • maternal exposure during pregnancy
  • neck injury
  • pulse absent
  • syncope
40-49:
  • drug ineffective
  • alveolitis fibrosing
  • nausea
  • asthenia
  • diabetes mellitus
  • diarrhoea
  • hypertension aggravated
  • pneumonia
  • chest pain
  • depression
50-59:
  • renal failure acute
  • oedema peripheral
  • arthralgia
  • dyspnoea
  • headache
  • pain
  • fatigue
  • flushing
  • vomiting
  • injury
60+:
  • drug ineffective
  • pain
  • dizziness
  • hypotension
  • nausea
  • anxiety
  • fatigue
  • cardiac failure congestive
  • dyspnoea
  • asthenia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lisinopril and Doxazosin mesylate?

Can you answer these questions?

More questions for: Lisinopril, Doxazosin mesylate

You may be interested in these reviews

More reviews for: Lisinopril, Doxazosin mesylate

On eHealthMe, Lisinopril (lisinopril) is often used to treat high blood pressure. Doxazosin mesylate (doxazosin mesylate) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.